Disclosure Of First-Time Adoption [Text Block]

Pharming Group N.V. - Filing #1883078

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Disclosure of first-time adoption [text block]	—	—	—	The Company applied for the first-time certain amendments, which are effective for annual periods beginning on or after	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	204,638,000 USD	—	—	—	—	8,737,000 USD	462,297,000 USD	256,431,000 USD	7,509,000 USD	—	273,167,000 USD	3,400,000 USD	—	192,916,000 USD	—	455,254,000 USD	—	7,429,000 USD	—	—	295,621,000 USD	7,312,000 USD	24,614,000 USD	447,130,000 USD	183,435,000 USD
Comprehensive income	—	— USD	11,054,000 USD	2,620,000 USD	13,674,000 USD	—	—	—	—	— USD	—	—	17,085,000 USD	—	— USD	—	— USD	—	1,089,000 USD	15,996,000 USD	—	—	—	—	—
Profit (loss)	—	— USD	— USD	13,674,000 USD	13,674,000 USD	—	—	—	—	— USD	—	—	— USD	—	— USD	—	— USD	—	15,996,000 USD	15,996,000 USD	—	—	—	—	—